JAK2 T875N, a causative novel activating germline mutation for familial essential thrombocytosis

Makoto Yoshimitsu

Presentation information

Oral Session

Oral Session 1-13B MPN: Clinical (1)

Fri. Oct 12, 2018 10:10 AM - 11:10 AM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Junko Ohyashiki (Department of Adveanced Callular Therapy, Tokyo Medical University, Japan)

[OS1-13B-1] JAK2 T875N, a causative novel activating germline mutation for familial essential thrombocytosis

Makoto Yoshimitsu¹, Miho Hachiman¹, Kotaro Shide², Kazuya Shimoda², Kenji Ishitsuka¹ (1.Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan, 2.Department of Gastroenterology and Hematology, University of Miyazaki, Miyazaki, Japan)

Abstract password authentication.
Password is written on a program and abstract book.